Please login to the form below

Not currently logged in

UK lags behind other countries in use of branded drugs

UK flag

ABPI claims use of innovative new treatments is lower than international average in seven out of 11 classes

From: Sales

NICE backs drug to cut alcohol consumption

Lundbeck selincro nalmefeneFinal guidance for Lundbeck’s Selincro for use on NHS in England

From: Sales

Novartis' heart failure drug on EMA's fast track

Novartis buildingCandidate is the first cardiovascular drug to get accelerated review in the EU

From: Sales

Boehringer’s Vargatef approved in the EU for lung cancer

EU flagMarks company’s second oncology drug to hit market

From: Sales

NICE overturns negative Glivec guidance

Novartis Glivec imatinib leukaemiaRecommends drug for reimbursement in GIST four years after rejection

FDA headquarters White Oak

The biosimilars are coming

Lilly on navigating the regulatory pathway for its insulin glargine

The potential of regulated wearable technology

New health-tracking technologies are set to be taken seriously as medical devices

Novartis gets creative on Pinterest

Invites users to create their own mosquito-killing story

Novartis Pinterest malaria social media

Monitoring the social media activity of HCPs

Do your research when planning a digital engagement strategy

Do your research

Jeffrey Gold appointed CEO of myoscience

Previously worked as president and COO at the firm

Online life sciences mapping tool launched

UK opens up database of 5,000 life science companies and sites

UK Life Sciences map

Featured jobs

Subscribe to our email news alerts


Add my company
Darwin Health Care

Strategic, tactical and creative Darwin Health Care is a European-based, international medical education company. We're part of the Grey Healthcare...

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...